Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2008 Jan 15;18(2):694-9. Epub 2007 Nov 21.

Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).

Author information

1
Department of Discovery Chemistry and Discovery Biology, Bristol-Myers Squibb Research and Development, Route 206 and Province Line Road, Princeton, NJ 08543-4000, USA. gott@cephalon.com

Abstract

Selective inhibitors of TNF-alpha Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl beta-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-alpha in human whole blood, selectivity against a panel of MMPs and oral bioavailability.

PMID:
18061445
DOI:
10.1016/j.bmcl.2007.11.059
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center